Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Roberto A. Espos"'
Autor:
Sachin N. Desai, Jong Sun Yeam, Roberto A. Espos, Antonio D. Ligsay, Remigio M. Olveda, Yeong Ok Baik, Ick Young Kim, Ajit Pal Singh, May B. Montellano, Seuk Keun Choi, Chan Wha Kim, Deok Ryun Kim, Jae Seung Yang, Sue Nie Park, Ju Yeon Park
Publikováno v:
Vaccine. 33:6360-6365
Currently, there are two oral cholera vaccines (OCV) that are prequalified by the World Health Organization. Both (Dukoral and Shanchol) have been proven to be safe, immunogenic, and effective. As the global supply of OCV remains limited, we assessed
Autor:
Ener Cagri Dinleyici, Serge Durviaux, Luis Rivera, Emre Alhan, Mehmet Ceyhan, Bruce L. Innis, Vijayalakshmi Chandrasekaran, Roberto A. Espos, Mohammed Yunus, Varsha K. Jain, Zafer Kurugöl, Opokua Ofori-Anyinam, Chukiat Sirivichayakul, Pornthep Chanthavanich, Adrian Caplanusi, Alejandro Cravioto, Pirunghul Kerdpanich, Kriengsak Limkittikul, Doris Maribel Rivera-Medina, Philippe Boutet, Khalequ Zaman, Ghassan Dbaibo, Beatriz P. Quiambao
Publikováno v:
The New England journal of medicine. 369(26)
BACKGROUND: Commonly used trivalent vaccines contain one influenza B virus lineage and may be ineffective against viruses of the other B lineage. We evaluated the efficacy of a candidate inactivated quadrivalent influenza vaccine (QIV) containing bot